An open standard for AI inference backed by Google Cloud, IBM, Red Hat, Nvidia and more was given to the Linux Foundation for ...
Inference is reshaping data center architecture, introducing a new and less forgiving set of network requirements.
Nvidia's upcoming GTC conference will reveal CEO Jensen Huang's AI hardware, software, and partnership plans. Investors anticipate new inference chips, updates on next-gen infrastructure like Rubin ...
Nvidia is reportedly developing a specialized processor aimed at accelerating AI inference, a move that could reshape how companies like OpenAI deploy their models. The push comes as Nvidia has also ...
Building on the inferencing acceleration introduced at Lenovo Tech World, this next phase of Hybrid AI execution expands the ...
NVIDIA shifted focus of GTC 2026 toward deploying AI inference apps across multiple industries, marking departure from its ...
Researchers present NorthPole – a brain-inspired chip architecture that blends computation with memory to process data efficiently at low-energy costs. Since its inception, computing has been ...
SEATTLE, Jan. 6, 2026 /PRNewswire/ -- Variant Bio, a genomics-driven AI drug discovery company, today announced the launch of Inference, the world's first agentic genomic drug discovery platform.
Lightbits Labs Ltd. today is introducing a new architecture aimed at addressing one of the most stubborn bottlenecks in large-scale artificial intelligence inference: the growing mismatch between the ...